Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 97 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/6/2008 First Published: 2/1/1994


1.		Phase III Randomized Study of Three Different Regimens Containing Fluorouracil in Patients With Stage II or III Rectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18				NCI				SWOG-9304 CAN-NCIC-CO11, CLB-9491, E-S9304, NCCTG-934751, RTOG-9403, CLB-C9491, INT-0144, NCT00002551, CO11

Last Modified: 5/8/2007


2.		Phase III Randomized Study of Bolus Fluorouracil and Leucovorin Calcium with Levamisole vs Continuous Infusion Fluorouracil with Levamisole as Adjuvant Therapy in Patients with High Risk Colon Cancer (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				adult				NCI				SWOG-9415 CLB-9498, E-S9415, NCCTG-S9415, INT-0153, NCT00002593

Last Modified: 12/12/2005


3.		Phase III Pilot Study of Standard Adjuvant 5-FU/LEV vs High-Dose Adjuvant 5-FU Alone vs No Adjuvant Therapy for Dukes' Stage B2/C Colon Cancer Following Radical Resection and Perioperative MITO/5-FU

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								SWS-SAKK-40/93 EU-94038

Last Modified: 7/1/1997


4.		Phase III Randomized Study of 5-FU/L-CF/LEV vs 5-FU/L-CF/PLCB, Each with Either High-Dose or Low-Dose L-CF, for Resected Colorectal Cancer (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								NCRI-QUASAR EU-94045, UKCCCR-QUASAR

Last Modified: 1/12/2007


5.		Phase III Randomized Study of 5-FU/LEV with vs without L-CF as Adjuvant Therapy for Radically Resected Dukes' Stage B2/B3/C Colon Cancer (Summary Last Modified 08/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								CNR-INTACC01 EU-95018

Last Modified: 8/1/1999


6.		Phase III Randomized Study of Adjuvant MOAB 17-1A plus 5-FU-Based Chemotherapy vs 5-FU-Based Chemotherapy Alone for Surgically Resected Stage III Adenocarcinoma of the Colon (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				GW-157-001 NCI-V96-0836

Last Modified: 9/7/2007


7.		Phase III Randomized Study of Surgery with or without Intraportal 5-FU/MITO Followed by 5-FU/LEV with or without CF in Stage II/III Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 75								BEL-GRECR-B EU-96001

Last Modified: 10/1/1996


8.		Phase III Randomized Study of Fluorouracil/Leucovorin Calcium vs Fluorouracil/Levamisole as Adjuvant Chemotherapy for Radically Resected Stage III Colon Cancer (Summary Last Modified 10/96)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								GER-AGEO-NRW EU-96017


9.		Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								MSKCC-75104

Last Modified: 1/24/2008 First Published: 11/1/1997


10.		Phase III Adjuvant Study of Levamisole vs Alfa Interferon 2a Plus Fluorouracil and Leucovorin Calcium for Intraperitoneal Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				75 and under				Other				CNR-TONE-01 EU-97011, NCT00003063

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute